Francis J. Bullock

Francis J. Bullock discloses dealings in 2 companies, chiefly GTC Biotherapeutics Inc and Array Biopharma Inc. Over a trading history stretching from 29 September 2006 to 30 September 2010, the count stands at 20 filings.

On the market, this insider has only ever bought: 2 purchases, €2,901 in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 17 share grants and 1 option exercise.

On 1 October 2010 came the latest disclosure, a share grant for €1,376 in GTC Biotherapeutics Inc. The most recent open-market purchase was published on 23 February 2007, 7,182 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.